1. If your organisation offers RAS tests, how many if any RAS tests have been provided for metastatic colorectal Cancer patients in 2014? 77

2. Of those metastatic colorectal cancer patients RAS tested, how many were RAS wild type? We do not hold this information in a retrievable form.  They are performed at the Queen Elizabeth hospital who you may wish to contact.
3. Within your organisation, how many patients have been treated in the last six months for metastatic colorectal cancer? 25

4. If possible, please split these patients by their current or most recent drug treatment, using the table below for convenience;  We are unable to split condition by drug.

5. Also within your organisation, how many patients have been treated in the last six months for head and neck cancer (squamous cell carcinoma)? 17

6. Of these patients, how many are locally advanced and how many are recurrent or metastatic head and neck cancer patients?
7. Locally advanced: 15
8. Recurrent and/or metastatic: 3

7. If possible, please split these patients by their current or most recent drug treatment, using the table below for convenience; We are unable to split condition by drug.

8. How are your patients funded, please state the number of patients by their funding route;

We are unable to provide this information as it is not held in an easily retrievable form and extracting this information would exceed the 18 hours staff time limit as laid down in the FOI Act, section 12.